Suppression of malignancy by Smad3 in mouse embryonic stem cell formed teratoma

Peng Li1, Ying Chen, Xiaoming Meng

  • 1Department of Chemical Pathology, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China.

Insights

Smad3 deficient mouse embryonic stem cells (ES cells) maintain self-renewal but show altered mesoderm development. These Smad3-/- ES cells form malignant teratomas, offering a new model for studying these tumors.

Area of Science:

  • Developmental Biology
  • Stem Cell Biology
  • Cancer Biology

Background:

  • Smad3-mediated transforming growth factor-beta (TGF-β)/Activin/Nodal signaling is crucial in biological processes.
  • The specific role of Smad3 in mouse embryonic stem cells (ES cells) remains underexplored.
  • Understanding Smad3 function in ES cells is vital for disease modeling and drug screening.

Purpose of the Study:

  • To investigate the function of Smad3 in mouse ES cells.
  • To characterize the developmental potential and tumorigenic properties of Smad3-deficient ES cells.

Main Methods:

  • Derivation and characterization of Smad3 knockout (Smad3-/-) and wild-type (WT) mouse ES cells.
  • Assessment of self-renewal and pluripotent gene expression.
  • Analysis of germ layer marker expression during embryoid body (EB) formation.
  • In vivo tumorigenicity assay via subcutaneous injection into nude mice.

Main Results:

  • Smad3-/- ES cells exhibit normal self-renewal and pluripotent gene expression.
  • A transient reduction in mesoderm lineage marker expression was observed in EBs derived from Smad3-/- ES cells.
  • Subcutaneous injection of Smad3-/- ES cells resulted in the formation of malignant immature teratomas, unlike mature teratomas from WT ES cells.

Conclusions:

  • Smad3 is not essential for mouse ES cell self-renewal but influences mesoderm differentiation.
  • Smad3 deficiency in ES cells promotes the development of malignant teratomas.
  • Smad3-/- ES cells provide a novel in vitro and in vivo model for studying malignant teratoma mechanisms.